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INTRODUCTION
Giant cell tumor (GCT) is found most often in the ends
of long bones and is essentially located in the epiphyseal or
epiphyseal-equivalent portions of bone. The rib is a rare site
for GCT with an incidence below one per cent (1). Even the
cases involving ribs, most were located in the posterior arc, i.e.,
the head and tubercle of ribs (2, 3). In this paper, we report
a case of GCT originating from the anterior arc of the rib.
CASE REPORT
A 40-yr-old man presented with a four-month history of a
progressively growing mass in the right anterior chest wall.
The mass was hard, fixed to the chest wall, and mildly tender.
It measured 8×5 cm. The overlying skin was normal. He had
no specific pulmonary symptoms. A chest roentgenogram
demonstrated a large, ill-defined mass with increased density
in the cartilaginous portion of the anterior arc of the right
second rib, and the anterior costochondral junction area of the
rib was destroyed. A lateral view showed that the mass mainly
grew posteriorly (Fig. 1). Computed tomography demonstrat-
ed a large lobulated soft tissue mass originating from the right
second rib. The mass showed heterogeneous contrast enhance-
ment and contained small necrotic or cystic components of low
density. The second rib near the costochondral junction showed
a forked appearance. The mass was attached to the aorta and
the superior vena cava (Fig. 2). A bone scan demonstrated a
focally increased uptake of forked appearance at the anterior
arc of the right second rib. The serum level of acid phosphatase
was increased (11.4 IU/L). But the serum levels of calcium,
phosphorus and alkaline phsphatase are in normal ranges, i.e.,
9.4 mg/dL, 2.8 mg/dL, 94 IU/L, respectively. And the levels
of tumor marker including alpha-fetoprotein, carcinoembry-
onic antigen, CA19-9 and CA125 are also in normal ranges.
The tumor was completely resected with the chest wall sur-
rounding the tumor including the upper hemisternum. The
mass was easily detached from the aorta and the superior vena
cava, however, adhesive lung was resected with the tumor. The
chest wall defect was covered with Marlex mesh. The resected
chest wall showed a relatively well demarcated tumor with
expansion into the surrounding soft tissue. The tumor was
8×6.5×6 cm in size. Hemorrhage, necrosis, and cyst forma-
tion with yellow capsule were noted in the cross section (Fig.
3). Histologically, the tumor was composed of round, oval
or spindle-shaped stromal mononuclear cells and uniformly
interspersed multinucleated giant cells (Fig. 4). The patholog-
ical diagnosis was a giant cell tumor of the right second rib. 
For the detection of recurrence, the serum level of acid phos-
phatase and bone scan were observed. During the 11 months
after surgery, the patient doing well without the evidence of
recurrence.
DISCUSSION
Giant cell tumor (GCT) of bone is an unusual neoplasm,
accounting for about 4-5% of all primary bone tumors. Malig-
nant GCT can arise de novo or via transformation from benign
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Giant Cell Tumor Originating from the Anterior Arc of the Rib
We report a case of giant cell tumor originating from the anterior arc of the rib. The
tumor and the surrounding chest wall were completely resected, and the chest wall
defect was covered with Marlex mesh. Giant cell tumor of the bone usually originates
from the epiphysis of long bones. Even when the tumor occur in ribs, it usually
occur in the posterior aspect. However, giant cell tumor should be included in the
differential diagnosis of a tumor originating from the anterior arc of the ribs.
Key Words : Bone Neoplasms; Giant Cell Tumors; Ribsneoplastic giant-cell lesion. The ends of long bone and epiphy-
seal portions of bone are the predilected sites for GCT. Indi-
vidual cases have been reported in the scapula, sternum, ribs
(4, 5). Gupta reviewed the literature on GCT, covered six series.
According to him, 26 cases of GCT in the rib were reported
out of 1,870 cases of bone GCT (6). Even in cases involving
the ribs, most cases were located in the posterior arc of the ribs.
Only a small number of cases were reported to originate from
the anterior arc of the ribs (6, 7). Because of its rarity, GCT
arising from the rib is difficult to diagnose, especially when
the tumor is located in the anterior arc of the ribs. In our case,
the initial impression of the musculoskeletal radiologist includ-
ed plasmacytoma, lymphoma, chondrosarcoma, metastatic
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Fig. 3. A cross section of the tumor shows hemorrhage, necro-
sis, and cyst formation with yellow capsule.
Fig. 4. Microscopically, the tumor shows oval, spindle shaped
stromal mononuclear cells and uniformly interspersed multinu-
cleated giant cells (H&E stain, ×100)
Fig. 2. Computed tomography demonstrates a large lobulated
soft tissue mass originating from the right second rib and attached
to the aorta and the superior vena cava (arrow).
Fig. 1. A lateral view of the sternum demonstrates a large mass,
which originated from the anterior chest wall and grew posteriorly.Giant Cell Tumor of the Rib 851
tumor, and malignant fibrous histiocytoma. GCT was not
included in his differential diagnosis.
Serum acid phosphatase values are suggested to be a useful
marker for diagnosis of GCT of the bone and for evaluation of
the efficacy of treatment of the tumor. The values were high
in 56% of GCT patients, and later decreased to normal values
after resection (8). In our patient, the level of serum acid phos-
phatase was high (11.4 IU/L) before surgery, and fell into the
normal range, i.e., 7.4 IU/L and 6.8 IU/L at the first month
and eleventh month after surgery, respectively. The normal
value of serum acid phosphatase as determined at our hospital
is below 8 IU/L.
Sometimes it is difficult to separate GCT from giant-cell-
rich osteosarcoma, malignant fibrous histiocytoma (MFH),
chondroblastoma, aneurysmal bone cyst (ABC) and brown
tumor. Giant-cell-rich osteosarcoma and MFH are character-
ized by nuclear anaplasia and abnormal mitotic figures. And in
the GCT, there is no neoplastic osteoid formation, which is the
most pathognomonic finding of giant-cell-rich osteosarcoma.
In chondroblastoma, chondroid matrix and plump, spindle-
shaped mononuclear cell component are present. Brown tumor
has characteristic biochemical findings of hyperparathyroidism.
GCT can be an underlying condition of secondary ABC. To
make a diagnosis of ABC, appropriate radiologic and clinical
findings of ABC are mandatory. This case had only small areas
of necrosis and cystic components. 
Wide excision with chest wall reconstruction has been proven
successful treatment of GCT originating from the rib. Radiation
therapy is not recommended because most of the malignant
transformations in GCT are associated with previous radiation
therapy (9). Even in cases with pulmonary metastasis, aggres-
sive surgical extirpation is recommended (10).
In summary, we described a rare case of GCT originating
from the anterior arc of the rib. We suggest that GCT should
be included in the differential diagnosis of a tumor originating
from the anterior arc of the ribs, and aggressive surgical resec-
tion be the first choice for the treatment of this tumor. 
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